Amedisys (AMED) Tops Q4 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports Fourth Quarter and Year End 2020 Financial Results
February 24, 2021 4:05 PM ESTBATON ROUGE, La., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2020.
Three-Month Periods Ended December 31, 2020 and 2019
Net service revenue increased $50.0Â million to $550.7Â million compared to $500.7Â million in 2019.Net income attributable to Amedisys, Inc. of $45.2Â million compared to $27.7Â million in 2019.Net income attributable to Amedisys, Inc. per diluted share of $1.36 compared to $0.83 in 2019.Adjusted Quarterly Results*
Adjusted EBITDA of $78.1Â million compared to $52.2Â million in 2019.Adjusted net service revenue of $550.7Â million compared to $500.7Â million in... More


